{"schema_version":"secwatch.filing_event.v1","accession":"0000920148-23-000040","form_type":"8-K","ticker":"LH","cik":"0000920148","company_name":"LABCORP HOLDINGS INC.","filed_at":"2023-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.810259+00:00","generated_at":"2026-06-14T06:16:09.936966+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Labcorp appoints Dr. Paul Rothman to Board of Directors","bullets":["Dr. Rothman appointed as independent director effective June 6, 2023, expanding board to 12 members (11 independent).","Rothman recently retired as CEO of Johns Hopkins Medicine, a $9B academic medical enterprise, after a decade of service.","He is a rheumatologist and molecular immunologist with leadership roles at Columbia University and University of Iowa.","Rothman currently serves on the boards of Merck & Co. and King Faisal Specialist Hospital and Research Center.","Compensation follows Labcorp's standard director compensation program as described in the March 2023 proxy statement."],"urls":{"canonical":"https://secwatch.observer/filing/0000920148-23-000040","json":"https://secwatch.observer/filing/0000920148-23-000040.json","markdown":"https://secwatch.observer/filing/0000920148-23-000040.md","text":"https://secwatch.observer/filing/0000920148-23-000040.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/920148/000092014823000040/0000920148-23-000040-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/920148/000092014823000040/lh-20230605.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T06:16:09.936966+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7116591196","claim":"Paul B. Rothman was appointed as member of the Board at LABCORP HOLDINGS INC..","evidence_excerpt":"Laboratory Corporation of America Holdings (“Labcorp”) today announced that on June 5, 2023, Labcorp’s Board of Directors (the “Board”) appointed Paul B. Rothman as a member of the Board, effective June 6, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/920148/000092014823000040/0000920148-23-000040-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"member of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}